文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

血清胱抑素C在预测ICU出院长期预后方面优于肌酐

Superiority of Serum Cystatin C Over Creatinine in Prediction of Long-Term Prognosis at Discharge From ICU.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论ICU出院时胱抑素C与1年死亡率呈近线性关联(HR 1.78),而肌酐呈J型关系且多数患者无显著关联,胱抑素C可能更适用于出院肾功能评估。

该回顾性观察性队列研究纳入3077例成人ICU存活者,比较ICU出院时胱抑素C与肌酐及其与1年死亡率的关系。出院时基于胱抑素C估算的肾小球滤过率低于60 mL/min/1.73 m者占44%,而基于肌酐者占26%。调整年龄、性别和合并症后,胱抑素C与死亡率呈近线性关联(第75百分位比第25百分位HR 1.78,95%CI 1.46-2.18),肌酐呈J型关系且多数患者无显著关联(HR 1.03,95%CI 0.87-1.2)。作者认为胱抑素C作为危重病后更有意义的肾功能指标值得进一步研究。

要点

  • ICU出院时基于胱抑素C估算的GFR<60 mL/min/1.73 m者占44%,基于肌酐估算者占26%,两者几乎相差一倍。
  • 调整年龄、性别和合并症后,胱抑素C与1年死亡率呈近线性关联,第75百分位比第25百分位HR 1.78(95%CI 1.46-2.18)。
  • 肌酐与1年死亡率呈J型关系,多数患者无显著关联,第75百分位比第25百分位HR 1.03(95%CI 0.87-1.2)。
  • 同时调整肌酐和胱抑素C后,出院肌酐较高反而与长期死亡率较低相关。
  • 在743例无急性肾损伤患者中,出院基于肌酐估算的GFR持续高估随访时基于肌酐估算的GFR,而基于胱抑素C估算的GFR与随访慢性肾脏病状态匹配良好。

适用人群与场景

  • 3077例成人ICU存活者,排除ICU出院后72小时内死亡、ICU停留不足24小时和终末期肾病患者。

研究设计与关键结果

  • 回顾性观察性队列研究,纳入3077例成人ICU存活者,比较ICU出院时胱抑素C与肌酐及其与1年死亡率的关系。
  • ICU住院期间血清胱抑素C与肌酐出现分离,至ICU出院时基于胱抑素C估算的GFR<60 mL/min/1.73 m者占44%,基于肌酐估算者占26%。
  • 在743例无急性肾损伤患者中,出院基于肌酐估算的GFR持续高估随访时基于肌酐估算的GFR,而出院基于胱抑素C估算的GFR与随访慢性肾脏病状态匹配良好。
  • 1年内535例(17.4%)死亡。
  • 调整年龄、性别和合并症后,胱抑素C与死亡率增加呈近线性关联,第75百分位比第25百分位HR 1.78(95%CI 1.46-2.18)。
  • 肌酐与死亡率呈J型关系,多数患者无显著关联,第75百分位比第25百分位HR 1.03(95%CI 0.87-1.2)。
  • 同时调整肌酐和胱抑素C后,出院肌酐较高与长期死亡率较低相关。

证据类型、等级与局限

  • 证据类型:回顾性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,与肌酐不同,胱抑素C始终与长期死亡率相关,可识别高危和低危患者,且与随访肾功能相关性更好。
  • 作者认为,相对于胱抑素C较低的肌酐似乎提示不良预后,会混淆单独解读肌酐。
  • 作者认为,胱抑素C作为危重病后更有意义的肾功能指标值得进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Renal outcomes after critical illness are seldom assessed despite strong correlation between chronic kidney disease and survival. Outside hospital, renal dysfunction is more strongly associated with mortality when assessed by serum cystatin C than by creatinine. The relationship between creatinine and longer term mortality might be particularly weak in survivors of critical illness.

DESIGN: Retrospective observational cohort study.

PATIENTS: In 3,077 adult ICU survivors, we compared ICU discharge cystatin C and creatinine and their association with 1-year mortality. Exclusions were death within 72 hours of ICU discharge, ICU stay less than 24 hours, and end-stage renal disease.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: During ICU admission, serum cystatin C and creatinine diverged, so that by ICU discharge, almost twice as many patients had glomerular filtration rate less than 60 mL/min/1.73 m when estimated from cystatin C compared with glomerular filtration rate estimated from creatinine, 44% versus 26%. In 743 patients without acute kidney injury, where ICU discharge renal function should reflect ongoing baseline, discharge glomerular filtration rate estimated from creatinine consistently overestimated follow-up glomerular filtration rate estimated from creatinine, whereas ICU discharge glomerular filtration rate estimated from cystatin C well matched follow-up chronic kidney disease status. By 1 year, 535 (17.4%) had died. In survival analysis adjusted for age, sex, and comorbidity, cystatin C was near-linearly associated with increased mortality, hazard ratio equals to 1.78 (95% CI, 1.46-2.18), 75th versus 25th centile. Conversely, creatinine demonstrated a J-shaped relationship with mortality, so that in the majority of patients, there was no significant association with survival, hazard ratio equals to 1.03 (0.87-1.2), 75th versus 25th centile. After adjustment for both creatinine and cystatin C levels, higher discharge creatinine was then associated with lower long-term mortality.

CONCLUSIONS: In contrast to creatinine, cystatin C consistently associated with long-term mortality, identifying patients at both high and low risk, and better correlated with follow-up renal function. Conversely, lower creatinine relative to cystatin C appeared to confer adverse prognosis, confounding creatinine interpretation in isolation. Cystatin C warrants further investigation as a more meaningful measure of renal function after critical illness.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Ravn B, Prowle JR, Mårtensson J, et al. Superiority of Serum Cystatin C Over Creatinine in Prediction of Long-Term Prognosis at Discharge From ICU. Crit Care Med. 2017. PMID: 28614196. doi:10.1097/CCM.0000000000002537

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。